Biotronik SE & Co. KG: Ischemia trials

The registry lists 11 Ischemia studies with Biotronik SE & Co. KG as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Assessment of Risk Factors for Appropriate ICD (Implantable Cardioverter-defibrillator) Intervention in Patients With Ischemic CardiomyopathyCompletedNCT04014946Not applicable
• BIOFLOW III Asia Registry Orsiro Stent SystemCompletedNCT01941290
• BIOFLOW-III Israel Satellite RegistryCompletedNCT01895712
• BIOFLOW-III Hungary Satellite RegistryTerminatedNCT01892917
• BIOFLOW-III Canada Satellite RegistryCompletedNCT01880242
• BIOFLOW-III Belgium Satellite RegistryCompletedNCT01831336
• BIOFLOW-III Austria Satellite RegistryCompletedNCT01667016
• BIOFLOW-III Sweden Satellite RegistryCompletedNCT01667003
• BIOFLOW-III Romania Satellite RegistryTerminatedNCT01593059
• BIOFLOW-III All-comers Orsiro Safety and Performance RegistryStatus unknownNCT01553526
• Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)CompletedNCT00906022Phase 4